In an effort to identify therapeutic intervention strategies for the treatment of COVID-19, we
have investigated a selection of FDA-approved small molecules and biologics that are …

COVID-19 pandemic has infected millions of people with mortality exceeding> 1 million.
There is an urgent need to find therapeutic agents that can help clear the virus to prevent …

COVID-19 vaccines based on the Spike protein of SARS-CoV-2 have been developed that
appear to be largely successful in stopping infection. However, therapeutics that can help …

The current epidemic of coronavirus disease-19 (COVID-19) caused by severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2) calls for the development of inhibitors of …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected millions within
just a few months, causing severe respiratory disease and mortality. Assays to monitor …

Coronavirus disease 2019 (COVID-19) has caused serious public health, social, and
economic damage worldwide and effective drugs that prevent or cure COVID-19 are …

Background and Purpose The SARS‐COV‐2 pandemic and the global spread of
coronavirus disease 2019 (COVID‐19) urgently call for efficient and safe antiviral treatment …

Antiviral treatments targeting the emerging coronavirus disease 2019 (COVID-19) are
urgently required. We screened a panel of already-approved drugs in a cell culture model of …

Combinations of direct-acting antivirals are needed to minimize drug resistance mutations
and stably suppress replication of RNA viruses. Currently, there are limited therapeutic …

The scientific community is focused on developing antiviral therapies to mitigate the impacts
of the ongoing novel coronavirus disease 2019 (COVID-19) outbreak. This will be facilitated …